Using a method developed for HIV, researchers have identified stable T cell vaccine targets in SARS-CoV-2. These stable targets, known as highly networked epitopes, are highly likely to be stable in different variants of the virus. The results provide a path forward for a broadly protective COVID-19 T cell vaccine.
from Latest Science News -- ScienceDaily https://ift.tt/2VbyG8k
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment